Skip to main content

US Pharmacy Market Size to Surpass USD 861.67 Billion by 2028, exhibiting a CAGR of 6.3%

As per the report by Fortune Business Insights, the global US pharmacy market size is projected to reach USD 861.67 Billion in 2028, at a CAGR of 6.3% during the forecast period, 2021-2028

US Pharmacy Market

US Pharmacy Market (2021-2028)
US Pharmacy Market (2021-2028)

Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) — The U.S. pharmacy market is projected to grow from USD 560.00 billion in 2021 to USD 861.67 billion by 2028 at a CAGR of 6.3% during the forecast period 2021-2028. Surging occurrence of aliments in U.S., and rising healthcare spending are few of the prime aspects fueling the growth of pharmaceuticals market.

This information is published by Fortune Business Insights™, in its report, titled, “U.S. Pharmacy Market, 2021-2028.”

Key Takeaways:

  • The increasing penetration and literacy regarding internet usage are anticipated to boost the overall market in the region.
  • By Type, Branded drugs accounted for a dominating market share in 2020.
  • Segment is anticipated to grow with the highest growth rate during the forecast period
  • The retail pharmacies segment held the major share in 2020
  • The mail-order/online pharmacies segment is anticipated to witness lucrative CAGR over the forecast period.


Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-pharmacy-market-106306


Industry Development

January 2021 Optum (UnitedHealth Group) collaborated with Change Healthcare, to offer software and data analytics, technology-empowered facilities and research, advisory and revenue cycle management offerings to assist in making health care work refined for all.

Discover the Leading Players Featured in the Report:

“Companies leading the US Pharmacy market are CVS Health Corporation (Rhode Island, U.S.), Walgreens Boots Alliance, Inc. (Illinois, U.S.), Cigna (Express Scripts) (Connecticut, U.S.), UnitedHealth Group (Optum) (Minnesota, U.S.), Walmart Inc. (Arkansas, U.S.), The Kroger Company (Ohio, U.S.), Rite Aid Corporation (Pennsylvania, U.S.), Albertsons Companies, Inc. (Idaho, U.S.)”


Report Scope & Segmentation

Report CoverageDetails
Forecast Period2021 to 2028
Forecast Period 2021 to 2028 CAGR6.3%
2028 Value ProjectionUSD 861.67 Billion
Base Year2020
Market Size in 2021USD 560.00 Billion
Historical Data2017 to 2019
No. of Pages74
Segments coveredType, Therapy Class, and Setting


Browse Complete Report Details: https://www.fortunebusinessinsights.com/u-s-pharmacy-market-106306


Segmentation

Type, Therapy Class, and Setting are studied for the Market

On the basis of type, the market is segregated into branded and generics. Branded drugs held a leading market share in 2020. The rising number of regulatory approvals for drugs coupled with a strong pipeline of dominating players is majorly responsible for its highest market share during the forecast period.

In terms of therapy class, the market is classified into oncology, anti-diabetics, autoimmune diseases, respiratory, pain, nervous system disorders, dermatology, antihypertensive, mental health, HIV antivirals, multiple sclerosis, anticoagulants, other cardiovascular, ADHD, GI products, viral hepatitis, sex hormones, antibacterial, hormonal contraception, ophthalmology, and others.

By setting, the market is divided into retail pharmacies, mail order/online pharmacies, and others.

By Type

  • Branded
  • Generics

By Therapy Class

  • Oncology
  • Anti-diabetics
  • Autoimmune diseases
  • Respiratory
  • Pain
  • Nervous System Disorders
  • Dermatology
  • Antihypertensive
  • Mental Health
  • HIV Antivirals
  • Multiple Sclerosis
  • Anticoagulants
  • Other Cardiovascular
  • ADHD
  • GI Products
  • Viral Hepatitis
  • Sex Hormones
  • Antibacterial
  • Hormonal Contraception
  • Ophthalmology
  • Others

By Setting

  • Retail Pharmacies
  • Mail Order/Online Pharmacies
  • Others (Non-retail Settings)


Quick Buy – US Pharmacy Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/106306


Drivers and Restraints

Growing Occurrence of Prolonged Disease and High Geriatric Population to Spur Demand

The amount of chronic disease-inflicted patients is promptly surging globally. There has been an incredible growth in the occurrences of chronic immune deficiencies, diabetes, and congestive heart failure among others. As per a record published by World Health Organization (WHO), chronic ailments impact nearly 133 million Americans, portraying 40% of the total population of the nation. Moreover, the growth in the geriatric population in the nation is also aiding the U.S. pharmacy market growth.

Nevertheless, the difficulties linked with the usage of these are a prime aspects that are probable to obstruct the growth of this market in the upcoming years.

Competitive Landscape

Collaborations among Companies to Safeguard Their Brand Values in Global Market

Fundamental players in the market are incessantly rooting for efficient tactics to endorse their products and establish their positions in the market. One such tactic is to launch novel products by teaming up with other companies to expand their reach to end-users.


FAQ’s

How big is the pharmacy market in the US?

The US Pharmacy Market size was 534.21 billion in 2020. It is expected to reach USD 861.67 billion by 2028.

What is the market trend in US pharmacy?

The US Pharmacy Market will exhibit a CAGR of 6.3% during the forecast period, 2021-2028


Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-pharmacy-market-106306


Major Table of Content:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. U.S. Pharmacy Market Analysis, Insights and Forecast, 2017-2028
  6. Competitive Analysis
  7. Strategic Recommendations


Related Reports:

ePharmacy Market Growth, Industry Analysis, Demand and Forecast

U.S. Reusable Medical Scrubs Market Size, Share, Opportunities & Analysis

U.S. Retail Clinics Market Share, Industry Analysis, Revenue Forecast and Opportunities

U.S. Acne Treatment Market Size, Share, Revenue Forecast and Opportunities


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.